Frontiers in Cell and Developmental Biology (Sep 2022)

The epigenetic aging, obesity, and lifestyle

  • Marica Franzago,
  • Marica Franzago,
  • Lucrezia Pilenzi,
  • Lucrezia Pilenzi,
  • Sara Di Rado,
  • Ester Vitacolonna,
  • Ester Vitacolonna,
  • Liborio Stuppia,
  • Liborio Stuppia

DOI
https://doi.org/10.3389/fcell.2022.985274
Journal volume & issue
Vol. 10

Abstract

Read online

The prevalence of obesity has dramatically increased worldwide over the past decades. Aging-related chronic conditions, such as type 2 diabetes and cardiovascular disease, are more prevalent in individuals with obesity, thus reducing their lifespan. Epigenetic clocks, the new metrics of biological age based on DNA methylation patterns, could be considered a reflection of the state of one’s health. Several environmental exposures and lifestyle factors can induce epigenetic aging accelerations, including obesity, thus leading to an increased risk of age-related diseases. The insight into the complex link between obesity and aging might have significant implications for the promotion of health and the mitigation of future disease risk. The present narrative review takes into account the interaction between epigenetic aging and obesity, suggesting that epigenome may be an intriguing target for age-related physiological changes and that its modification could influence aging and prolong a healthy lifespan. Therefore, we have focused on DNA methylation age as a clinical biomarker, as well as on the potential reversal of epigenetic age using a personalized diet- and lifestyle-based intervention.

Keywords